Read the latest blogs from across our work within the secondary breast cancer community. From blogs on fundraising, research findings, information sharing, corporate achievements, community support and stories, celebrate with us as we work together to Make 2nds Count.

Covid-19 Useful Information
During such an uncertain time we are living through, here at Make 2nds Count, we understand that when you are already living with Secondary Breast Cancer it is also very frightening time. To make things easier to navigate we have gathered some useful resources.

Meet our Champions - Liz
Hi my name is Liz, I’m 54 and I live with my wife and our son in Edinburgh. I’m fortunate to be surrounded by family and friends here.

Edinburgh Breast Cancer Symposium
We were delighted to be invited to attend the Edinburgh Breast Cancer Special Symposium on Saturday 29th February. Our Head of Fundraising Emma was joined by our patient champions, Claire, Karen H and Karen T.

Secondary Breast Cancer: Where Can It Impact?
One of the most common questions we're asked about secondary breast cancer is; what parts of the body does it impact? When breast cancer cells spreads to another site within the body through the lymphatic system or blood stream it is commonly referred to as metastases or ‘mets.’ The most common areas that breast cancer cells spread to are the bones, brain, liver, lungs and skin.

Meet Our Champions: Claire
I was diagnosed with primary Breast Cancer in October 2015, at age 37. My treatment plan was neoadjuvant chemotherapy, radiotherapy, followed by a mastectomy with axillary lymph node clearance.
Kicking Cancer's Ass in The Gym
I've always been a bit of a fitness freak embracing the Green Goddess high cut leotards and shiny leggings of the 80s to the trendy but subtly branded sportswear of today. I've done aerobics, step, body combat, body pump, pilates, running, yoga and some heavy weight lifting....oh and you can throw some salsa dancing into all that as well.
What Is Secondary Breast Cancer?
We hear about breast cancer on almost a daily basis, yet many people have never heard of secondary breast cancer and even though the disease kills on average 1,000 people every single month in the UK alone. So, what is Secondary Breast Cancer?
Why are recruitment rates for trials dropping?
Why isn’t every patient with cancer offered a clinical trial? Why are my six little pills not available to every metastatic Her2 patient now?
A Christmas filled with cheer and tinged with fear…
It’s Christmas!!! The dulcet tones of Noddy Holder fills the house and I can’t help but smile.

Our founder makes the top 10!
Edinburgh Evening News Hot 30 list celebrates the key figures from the world of politics, sport, showbiz and beyond - giving them the recognition they deserve. Make 2nds Count founder Lisa Fleming came in at number 8!

Concert Review
Review by Martin Gray (Alledinburghtheatre.com) Christmas came early in aid of Make 2nds Count at St Giles’ Cathedral on Friday night. The shops may be decorated with tinsel, Channel Five may be filling its afternoons with festive films, but it takes a lot to get me into the Christmas spirit before 1 December.

Sunshine on Dalkeith
I was first diagnosed with primary breast cancer three years ago but unfortunately last year I found out that this had progressed to secondary breast cancer. Secondary breast cancer means although treatable it’s no longer curable, and I wanted to make more people aware of this.

Forth Rail Bridge Abseil
In October 2019, 10 participants got together for Make 2nds Count. They challenged their selves in this exhilarating and unique challenge which allows you to abseil (free-fall style like S.A.S) from one of Scotland’s best loved landmark.

1st Inaugural Gala Ball
We held our inaugural Gala Ball in March 2019, in the picturesque setting of Prestonfield House. The evening was filled with so many highs, from the reception drinks, with a flash mob dance troupe, to the rock choir who sang their hearts out to the outstanding cheque presentation where founder Lisa Fleming handed over a £100,000 check to Dr. Olga Oikonomidou from University of Edinburgh’s Breast Cancer Translational Research Group at the Edinburgh Cancer Research Centre.